- Research article
- Open Access
The kinase MSK1 is required for induction of c-fos by lysophosphatidic acid in mouse embryonic stem cells
© Schuck et al; licensee BioMed Central Ltd. 2003
- Received: 18 April 2003
- Accepted: 26 May 2003
- Published: 26 May 2003
The regulation of the immediate-early gene c-fos serves as a paradigm for signal-activated gene induction. Lysophosphatidic acid is a potent serum-borne mitogen able to induce c-fos.
Analysing the signalling events following stimulation of mouse embryonic stem cells with serum and lysophosphatidic acid, we show that the extracellular signal-regulated kinase (ERK) pathway is involved in mediating c-fos induction. We demonstrate that the ERK-activated kinase MSK1 is required for full c-fos promoter activation, as well as for the phosphorylation of cAMP-responsive element (CRE) binding proteins. We propose that MSK1 contributes to ERK-mediated c-fos promoter activation by targeting CRE binding proteins.
These results show that MSK1 is an important ERK-activated mediator of mitogen-stimulated c-fos induction. In addition, they indicate that MSK1 could act through CRE binding proteins to achieve c-fos promoter activation. Thus, they further our understanding of the complex regulation of the model immediate-early gene c-fos.
- Serum Response Factor
- CREB Phosphorylation
- Serum Response Element
- Wild Type Embryonic Stem Cell
Lysophosphatidic acid (LPA) is an intercellular mediator involved in inflammation and wound healing . It is released by activated platelets and leukocytes, and is one of the most potent mitogens found in serum. LPA acts through G-protein-coupled receptors to activate a number of intracellular signalling pathways including mitogen-activated protein (MAP) kinase cascades and Rho signalling. This leads to cellular responses such as proliferation, differentiation and suppression of apoptosis. One way in which these effects are mediated is induction of immediate-early genes such as c-fos.
The c-fos promoter has been extensively studied as a model for signal-activated gene induction [2, 3]. It contains several regulatory elements, namely a serum response element (SRE), a cAMP-responsive element (CRE), a sis-inducible element, and an AP-1-like site, which serve to integrate input from a host of signalling pathways. These promoter elements are strongly interdependent. Mutation of one of them inhibits c-fos activation through any of the other elements, suggesting that they are connected by protein complexes .
The c-fos SRE is constitutively occupied by the transcription factor serum response factor (SRF) . Its presence allows members of the Ets family ternary complex factors (TCFs) to bind to the SRE . A well understood mechanism underlying c-fos induction is phosphorylation of TCFs by MAP kinases, leading to transactivation . SRF bound to SRE reporter genes can also be activated independently of TCFs by at least two signalling pathways, one involving the small GTPase Rho, while the other is regulated by phosphatidylinositol 3-kinase [7, 8]. However, how these pathways contribute to the control of the endogenous c-fos gene is not clear. In addition, SRF is phosphorylated in a signal-regulated manner by several kinases, including MAP kinase-activated protein kinase-1 (MAPKAP-K1, also called RSK) and MAPKAP-K2 [9, 10]. SRF phosphorylation has been correlated with enhanced DNA binding [9, 11], but so far there is no direct evidence for a functional role of SRF phosphorylation.
The CRE is bound by CRE binding protein family members, including CREB and ATF1. Upon phosphorylation, they recruit the co-activator CREB binding protein (CBP), thus effecting transactivation. Phosphorylation of CREB can be induced by several distinct pathways. For instance, in response to elevated intracellular cAMP levels, CREB is phosphorylated by protein kinase A. Growth factors and cellular stresses induce CREB phosphorylation by activating downstream targets of the classical extracellular signal-regulated kinase (ERK) pathway and the stress-activated p38 pathway, respectively . MAPKAP-K1b/RSK2 was initially thought to be the major growth factor-regulated CREB kinase [13, 14], but recent evidence indicates that mitogen- and stress-activated kinases (MSKs) play this role [15–17].
Signal-dependent changes in chromatin structure as part of the nucleosomal response constitute an additional level of regulation . Stimulation rapidly induces histone phosphorylation and acetylation at the loci of immediate-early genes . Histone kinase activity has been shown for both MAPKAP-K1b/RSK2 and MSK1, while CBP possesses histone acetyltransferase activity [20–22]. Therefore, these molecules might play a dual role by contributing to c-fos induction at the level of chromatin remodeling as well as promoter activation.
Transfection experiments have shown that LPA targets the SRE to activate the c-fos promoter. This was proposed to occur through a Rho-dependent pathway, independently of TCFs and MAP kinases . However, a more recent study concluded that induction of the endogenous c-fos gene by LPA requires the ERK pathway, but not Rho signalling . In addition, some c-fos induction by LPA remains in cells that lack SRF and thereby signalling to the SRE , indicating that other promoter elements may contribute to c-fos induction.
Here, we analyse the signalling events leading from LPA stimulation to c-fos promoter activation. We confirm that regulation of the endogenous c-fos gene involves the ERK pathway and provide direct genetic evidence for a role of MSK1 in this process. Furthermore, we suggest phosphorylation of CRE binding proteins by MSK1 as a mechanism to link the ERK pathway to the c-fos promoter, thus allowing for SRF-independent c-fos induction.
The ERK pathway is involved in c-fos induction by serum and LPA
MSK1 is required for c-fos induction by serum and LPA
MSK1 is required for the induction of CREB phosphorylation by serum and LPA
Induction of c-fos through the ERK pathway can occur in the absence of SRF
In this study, we show that the ERK pathway is involved in LPA signalling to the c-fos promoter in mouse ES cells. We demonstrate that MSK1 is necessary for full c-fos promoter activation as well as for phosphorylation of CRE binding proteins, and we provide evidence for SRF-independent c-fos induction through the ERK pathway.
The activation profiles of MAP kinases show ERK1/ERK2 and JNK1/JNK2 activation by serum and LPA, while only a slight p38 activation could be detected (Figure 1). These results are consistent with previous reports for the serum stimulation of ES cells . Our experiments do not address the role of JNK1/JNK2 in c-fos induction. However, since activation of a chromosomal SRE reporter gene by LPA has been found to require JNK-mediated histone hyperacetylation , JNK1/JNK2 may be involved in c-fos regulation at the level of chromatin remodelling.
The kinetics of ERK1/ERK2 activation and c-fos induction, as well as the reduced c-fos induction in the presence of the ERK pathway inhibitors PD98059 and Ro318220 are consistent with a role of ERK1/ERK2 in c-fos induction by serum and LPA (Figure 1 and 2). A major mechanism by which ERK1/ERK2 mediate c-fos induction, is phosphorylation of TCFs . However, even though TCFs can bind the c-fos SRE only in the presence of SRF, the knockout of SRF does not completely abolish c-fos induction . This suggests a role for other c-fos promoter elements. We show that in Srf(-/-) ES cells, the residual response to serum is still PD98059- and Ro318220-sensitive (Figure 6), indicating SRF-independent signalling through the ERK cascade. It should be noted, however, that data with Ro318220 have to be treated with caution as it inhibits several kinases .
A possible mechanism for the residual c-fos induction in Srf(-/-) ES cells is activation of CREB bound to the c-fos CRE. Phosphorylation of CREB leading to transactivation has been shown to occur downstream of ERK1/ERK2 in response to mitogenic stimuli in a variety of cell types . To examine a role for MSK1 in this process, we used ES cells lacking MSK1 . Induction of c-fos in these cells was reduced by more than 50% as judged by quantitative RT-PCR as well as RNase protection (Figure 4 and unpublished results). Transfection of dominant negative CREB into fibroblasts has been shown to reduce c-fos induction to a similar extent . Consistent with these results, we found that serum and LPA induce CREB phosphorylation in wild type cells, and that this is greatly reduced in Msk1(-/-) ES cells (Figure 5). Some CREB phosphorylation remains in the absence of MSK1, indicating that another CREB kinase exists in these cells. As MSK2 activity is undetectable in ES cells (unpublished results), the identity of this kinase remains unclear. Similarly, an undefined ERK-regulated CREB kinase distinct from MSK1 and MSK2 exists in fibroblasts .
The interpretation of some of the residual c-fos induction in Srf(-/-) ES cells being due to CREB phosphorylation implies that the CRE is able to mediate c-fos activation in the absence of SRF. In the presence of SRF, CRE activation by mitogenic stimuli appears to be insufficient for c-fos activation, but requires co-operation of CREB and SRF . Possibly, this requirement is relieved in cells lacking SRF. The reduction of c-fos induction by more than 50% in Msk1(-/-) ES cells being completely mediated by the CRE seems at odds with the 60–70% reduction seen in Srf(-/-) ES cells , where the effect should be due to a nonfunctional SRE. This may reflect interactions between the different promoter elements , with a lack of transactivation at the CRE reducing the effectiveness of the SRE. In addition, it may indicate multiple roles for MSK1. Another potential function for MSK1 is histone phosphorylation as part of the nucleosomal response . MSK1 could therefore play a dual role by controlling c-fos at the level of chromatin remodelling as well as promoter activation. It was, however, not possible to examine this in ES cells due to the high level of mitosis-related histone phosphorylation in these cells that never become truly quiescent . Also, to more directly evaluate the role of the CRE in c-fos regulation, it would be helpful to analyse the activation of reporter genes driven by a minimal CRE, the wild type c-fos promoter and mutant derivatives of the c-fos promoter in which particular promoter elements are inactivated. However, we failed to establish these assays in ES cells as we were unable to efficiently activate exogenously added reporter constructs.
Besides MSK1, other kinases could act in a similar fashion. MAPKAP-K1/RSK also lies downstream of ERK1/ERK2, and it has been suggested to phosphorylate CREB , but see [15–17], and histone H3 , but see . However, in MAPKAP-K1b/RSK2-deficient cells derived from Coffin-Lowry patients, serum-induced CREB phosphorylation and c-fos induction was normal . This argues against a role of MAPKAP-K1/RSK in mediating the response to serum and also to LPA, which is a serum constituent.
Our results show that MSK1 is an important ERK-activated mediator of mitogen-induced c-fos activation. In addition, they indicate that MSK1 may effect activation of the c-fos promoter by phosphorylating CRE binding proteins. To further delineate the mechanisms leading to immediate-early gene activation, the respective functions of the CREB kinase and the histone kinase activity of MSK isoforms need clarification.
Cell culture and stimulation
Mouse embryonic stem cells lacking SRF or MSK1 have been described previously [16, 27]. Unless indicated otherwise, the knockout cell lines used were E100 Srf(-/-) and Msk1(-/-) No.4. Cells were cultured as described . For stimulation experiments followed by quantitative RT-PCR, 105 cells were seeded on 3.5 cm gelatinised tissue culture plates, grown in complete medium for 24 h and incubated in serum-free medium as indicated in the figures. For most other experiments, cells were grown to confluence in complete medium, followed by incubation in serum-free medium as indicated in the figures. Cells were stimulated with fetal calf serum (Life Technologies) or LPA (Sigma) at final concentrations of 15% (v/v) and 20 μM, respectively. PD98059 and Ro318220 (Calbiochem) were used at final concentrations of 25 μM and 5 μM, respectively.
For analysis of MAP kinase and CREB phosphorylation, cells were lysed directly into SDS sample buffer , run on polyacrylamide gels and transferred onto nitrocellulose. Antibodies recognising phosphorylated ERK1/ERK2 (Thr202/Tyr204), JNK1/JNK2 (Thr183/Tyr185), p38 (Thr180/Tyr182), total ERK1/ERK2 or total p38 were from New England Biolabs. The antibody that recognises phospho-CREB (Ser133) and phospho-ATF1 (Ser63) was from Upstate. HRP-conjugated secondary antibodies were from Pierce, and detection was performed using the enhanced chemiluminescence reagent from Amersham.
For quantitative RT-PCR, total RNA was isolated using the RNeasy kit (Qiagen) and treated with 10 U DNase I (Boehringer). 1 μg RNA was converted to cDNA using oligo-(dT)15 primers (MWG Biotech) and 200 U M-MLV Reverse Transcriptase (Promega). 1/50 of this reaction was included in each 10 μl PCR reaction. Quantitative PCR, data acquisition and calculation of relative mRNA levels was done as described . Primers: c-fos forward CCTGCCCCTTCTCAACGAC, c-fos reverse GCTCCACGTTGCTGATGCT, hprt forward GCCTAAGATGAGCGCAAGTTG, hprt reverse TACTAGGCAGATGGCCAAAGG. For semi-quantitative RT-PCR, RNA was isolated as above and RT-PCR was done using the Access RT-PCR System (Promega) with mouse c-fos primers from Ambion.
Immunoprecipitation kinase assays
Cell lysates were prepared as described . Protein concentrations of the lysates were determined by Bradford assay. Immunoprecipitation kinase assays were carried out as described  using an antibody that recognises residues 384–402 of MSK1 . MSK1 was assayed after immunoprecipitation from 1 mg of cell lysate pre-cleared with protein G sepharose. One unit of activity was the amount that catalysed the phosphorylation of 1 nmole of the substrate GST-CREB in 1 min.
We thank members of the Nordheim lab for discussion and advice. This work was funded by the DFG and the United Kingdom Medical Research Council through grants to AN (No 120/7–4) and JSCA. AS acknowledges support by the European TMR Cell Signalling Network.
- Moolenaar WH: Development of our current understanding of bioactive lysophospholipids. Ann NY Acad Sci. 2000, 905: 1-10.View ArticlePubMedGoogle Scholar
- Treisman R: Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 1995, 14: 4905-4913.PubMed CentralPubMedGoogle Scholar
- Hazzalin CA, Mahadevan LC: MAPK-regulated transcription: a continuously variable gene switch?. Nat Rev Mol Cell Biol. 2002, 3: 30-40. 10.1038/nrm715View ArticlePubMedGoogle Scholar
- Robertson LM, Kerppola TK, Vendrell M, Luk D, Smeyne RJ, Bocchiaro C, Morgan JI, Curran T: Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron. 1995, 14: 241-252.View ArticlePubMedGoogle Scholar
- Herrera RE, Shaw PE, Nordheim A: Occupation of the c-fos serum response element in vivo by a multi-protein complex is unaltered by growth factor induction. Nature. 1989, 340: 68-70. 10.1038/340068a0View ArticlePubMedGoogle Scholar
- Shaw PE, Schröter H, Nordheim A: The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell. 1989, 56: 563-572.View ArticlePubMedGoogle Scholar
- Hill CS, Wynne J, Treisman R: The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell. 1995, 81: 1159-1170.View ArticlePubMedGoogle Scholar
- Poser S, Impey S, Trinh K, Xia Z, Storm DR: SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation. EMBO J. 2000, 19: 4955-4966. 10.1093/emboj/19.18.4955PubMed CentralView ArticlePubMedGoogle Scholar
- Rivera VM, Miranti CK, Misra RP, Ginty DD, Chen RH, Blenis J, Greenberg ME: A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mol Cell Biol. 1993, 13: 6260-6273.PubMed CentralView ArticlePubMedGoogle Scholar
- Heidenreich O, Neininger A, Schratt G, Zinck R, Cahill MA, Engel K, Kotlyarov A, Kraft R, Kostka S, Gaestel M, Nordheim A: MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo. J Biol Chem. 1999, 274: 14434-14443. 10.1074/jbc.274.20.14434View ArticlePubMedGoogle Scholar
- Janknecht R, Hipskind RA, Houthaeve T, Nordheim A, Stunnenberg HG: Identification of multiple SRF N-terminal phosphorylation sites affecting DNA binding properties. EMBO J. 1992, 11: 1045-54.PubMed CentralPubMedGoogle Scholar
- Shaywitz AJ, Greenberg ME: CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 1999, 68: 821-861. 10.1146/annurev.biochem.68.1.821View ArticlePubMedGoogle Scholar
- Xing J, Ginty DD, Greenberg ME: Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 1996, 273: 959-963.View ArticlePubMedGoogle Scholar
- De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P: Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci USA. 1998, 95: 12202-12207. 10.1073/pnas.95.21.12202PubMed CentralView ArticlePubMedGoogle Scholar
- Deak M, Clifton AD, Lucocq JM, Alessi DR: Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 1998, 17: 4426-4441. 10.1093/emboj/17.15.4426PubMed CentralView ArticlePubMedGoogle Scholar
- Arthur JS, Cohen P: MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Letters. 2000, 482: 44-48. 10.1016/S0014-5793(00)02031-7View ArticlePubMedGoogle Scholar
- Wiggin GR, Soloaga A, Foster JM, Murray-Tait V, Cohen P, Arthur JS: MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol. 2002, 22: 2871-2881. 10.1128/MCB.22.8.2871-2881.2002PubMed CentralView ArticlePubMedGoogle Scholar
- Thomson S, Mahadevan LC, Clayton AL: Independent dynamic regulation of histone phosphorylation and acetylation during immediate-early gene induction. Semin Cell Dev Biol. 1999, 10: 205-214. 10.1006/scdb.1999.0302View ArticlePubMedGoogle Scholar
- Clayton AL, Rose S, Barratt M, Mahadevan LC: Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J. 2000, 19: 3714-3726. 10.1093/emboj/19.14.3714PubMed CentralView ArticlePubMedGoogle Scholar
- Sassone-Corsi P, Mizzen CA, Cheung P, Crosio C, Monaco L, Jacquot S, Hanauer A, Allis CD: Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science. 1999, 285: 886-891. 10.1126/science.285.5429.886View ArticlePubMedGoogle Scholar
- Thomson S, Clayton AL, Hazzalin CA, Rose S, Barratt MJ, Mahadevan LC: The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J. 1999, 18: 4779-4793. 10.1093/emboj/18.17.4779PubMed CentralView ArticlePubMedGoogle Scholar
- Ogryzko VV, Schlitz RL, Russanova V, Howard BH, Nakatani Y: The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 1996, 87: 953-959.View ArticlePubMedGoogle Scholar
- Gineitis D, Treisman R: Differential usage of signal transduction pathways defines two types of serum response factor target gene. J Biol Chem. 2001, 276: 24531-24539. 10.1074/jbc.M102678200View ArticlePubMedGoogle Scholar
- Schratt G, Weinhold B, Lundberg AS, Schuck S, Berger J, Schwarz H, Weinberg RA, Ruther U, Nordheim A: Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells. Mol Cell Biol. 2001, 21: 2933-2943. 10.1128/MCB.21.8.2933-2943.2001PubMed CentralView ArticlePubMedGoogle Scholar
- Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995, 270: 27489-27494. 10.1074/jbc.270.46.27489View ArticlePubMedGoogle Scholar
- Alessi DR: The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1beta (Rsk-2) and p70 S6 kinase. FEBS Lett. 1997, 402: 121-123. 10.1016/S0014-5793(96)01510-4View ArticlePubMedGoogle Scholar
- Weinhold B, Schratt G, Arsenian S, Berger J, Kamino K, Schwarz H, Ruther U, Nordheim A: Srf(-/-) ES cells display non-cell-autonomous impairment in mesodermal differentiation. EMBO J. 2000, 19: 5835-5844. 10.1093/emboj/19.21.5835PubMed CentralView ArticlePubMedGoogle Scholar
- Chen F, Ma L, Parrini MC, Mao X, Lopez M, Wu X, Marks PW, Davidson L, Kwiatkowski DJ, Kirchhausen T, et al: Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr Biol. 2000, 10: 758-765. 10.1016/S0960-9822(00)00571-6View ArticlePubMedGoogle Scholar
- Alberts SA, Geneste O, Treisman R: Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation. Cell. 1998, 92: 475-487.View ArticlePubMedGoogle Scholar
- Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000, 351: 95-105. 10.1042/0264-6021:3510095PubMed CentralView ArticlePubMedGoogle Scholar
- Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, Vinson C: A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol Cell Biol. 1998, 18: 967-977.PubMed CentralView ArticlePubMedGoogle Scholar
- Bonni A, Ginty DD, Dudek H, Greenberg ME: Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals. Mol Cell Neurosci. 1995, 6: 168-183. 10.1006/mcne.1995.1015View ArticlePubMedGoogle Scholar
- Williams MR, Arthur JS, Balendran A, van der Kaay J, Poli V, Cohen P, Alessi DR: The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol. 2000, 10: 439-448. 10.1016/S0960-9822(00)00441-3View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.